Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Robbins LLP is Investigating Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability of its IMPACT Phase 2b MASH Trial
-
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (NYSE: NVO)...
-
Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit
-
Robbins LLP is Investigating Allegations that Lockheed Martin Corporation (LMT) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Sable Offshore Corp. (SOC) Misled Investors Regarding Oil Production.
-
Robbins LLP is Investigating Allegations that Replimune Group, Inc. (REPL) Misled Investors Regarding the Viability of its IGNYTE Trial
-
Robbins LLP is Investigating Allegations that Luminar Technologies, Inc. (LAZR) Failed to Disclose that its President and CEO was Engaged in Misconduct
-
Robbins LLP is Investigating Allegations that Fiserv, Inc. (FI) Misled Investors Regarding the Growth Prospects of its Clover Platform
-
Robbins LLP is Investigating Allegations that Flywire Corporation (FLYW) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel